Bristol/Medarex’s Ipilimumab Toxic, But Could Extend Life

Melanoma drug’s side effects indicate immune-boosting cancer drug’s effectiveness, investigator tells “The Pink Sheet” DAILY.

More from Archive

More from Pink Sheet